NCT05122039Recruiting
ProspectIve Cohort psoriASiS fOllow-up (PICASSO)
Source: ClinicalTrials.gov · Last updated 1 Jul 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The main purpose of the PICASSO-project is to facilitate future psoriasis-research in dermatology. This register biobank will enable us to perform research in the field of metabolomics, mRNA-expression, cardiovascular impact and the microbiome. The final aims are patient stratification, better insight in disease-evolution and improved understanding of markers that predispose to severe disease.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 3 Nov 2021
- Start date
- 20 Oct 2021
- Primary completion date
- 19 Oct 2032
- Lead sponsor
- Universitaire Ziekenhuizen KU Leuven
- Diseases
- Psoriasis
- NCT number
- NCT05122039
What you commit to
- Study type: Observational
- Planned participants: 200
- From 20 Oct 2021 to the primary completion date, 19 Oct 2032
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- disease duration longer than 3 years
Other
- unwilling or unable to understand and sign the informed consent
Who the study is looking for
- Clinical signs of Psoriasis since \>3 years
- adults (70 years old or less) and children (\>12 years old)
- willing and able to understand and sign the informed consent (plus legal representative in case of a minor)
Age in the registry: 12 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UZ Leuven Coordinator of this site? Confirm its status | Leuven | Belgium | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.